Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q3 2013 · 10-Q
Revenue$252.00$252.00+995.7% vs Q3 2012 Net Income-$5.13K-$5.13KN/M vs Q3 2012 EPS Diluted$0.00$0.00— vs Q3 2012 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Margins · derivedGross margin100.0%±0.0 pt vs Q3 2012
Operating margin-1877.0%
Net margin-2036.1%+18746.5 pt vs Q3 2012
ended Sep 30, 2013 · filed Nov 15, 2013 · 46 d after period end